The effect of HIV exposure and infection on immunity to TB in children

HIV暴露和感染对儿童结核病免疫力的影响

基本信息

批准号：
10314021
负责人：
Cheryl Liane Day
金额：
$ 77.49万
依托单位：
UNIVERSITY OF WASHINGTON
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-01-01 至 2023-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10314021
关键词：
Activities of Daily Living Address Adult Aggressive course Bacille Calmette-Guerin vaccination CD4 Positive T Lymphocytes Cells Cessation of life Characteristics Child Childhood Chromatin Clinical Cohort Studies Cryopreservation DNA Data Development Disease Epigenetic Process Genus Mycobacterium HIV HIV Infections HIV antiretroviral HIV/TB Heterochromatin High Prevalence Immune Immune response Immunity Immunize Infant Infant Mortality Infection Inflammatory Response Pathway Innate Immune Response Kenya Life Longitudinal cohort Mediating Morbidity - disease rate Mycobacterium tuberculosis Natural Killer Cells Neonatal Neonatal Mortality Newborn Infant Pediatric cohort Peripheral Blood Mononuclear Cell Phenotype Populations at Risk Predisposition Prevalence Reporting Risk Site Specimen Technology Testing Training Tuberculosis Umbilical Cord Blood Vaccination Virus adaptive immune response antiretroviral therapy co-infection cofactor cohort epigenome infant infection infection risk insight monocyte mortality mycobacterial novel pathogen pathogenic bacteria pathogenic fungus pathogenic virus pediatric human immunodeficiency virus prenatal exposure preventive intervention repository response transcriptome tuberculosis immunity

项目摘要

Project Summary / Abstract Over one million new cases of tuberculosis (TB) and 239,000 TB-related deaths occur in children each year. Despite evidence that HIV exposure in children is associated with a markedly increased risk of infection with Mycobacterium tuberculosis (Mtb) and development of TB disease, few studies have explored mechanisms for HIV-related susceptibility to TB in children. HIV-exposed uninfected children (HEU) are exposed in utero to both maternal HIV and anti-retroviral therapy (ART) and these exposures may influence subsequent immune responses to Mtb. In settings with high prevalence of HIV and TB, newborns typically receive BCG vaccination within the first few days of life, which confers some protection against severe forms of TB in young children. Interestingly, BCG vaccination has also been recognized to confer non-specific beneficial effects, including reduced neonatal and infant mortality. Moreover, vaccination with BCG is associated with enhanced innate immune responses to mycobacteria as well as heterologous pathogens, a phenomenon termed “trained immunity”. Epigenetic reprogramming of innate immune cells, including monocytes and NK cells, is one mechanism identified that contributes to BCG-induced trained immunity. The effect of maternal HIV exposure and infant HIV infection on induction of trained immunity to Mtb in BCG-vaccinated infants has not been described. Our studies will characterize innate and adaptive immune responses to mycobacteria, cofactors such as ART that may influence immune responses, and the implications of these immune responses for susceptibility to pediatric Mtb infection. We will test the hypotheses that (1) maternal HIV exposure and infant HIV infection dampen induction of trained immunity to Mtb via epigenetic reprogramming of innate immune cells in BCG-vaccinated infants; and (2) ART enhances innate and adaptive anti-mycobacterial immune responses in HIV-infected children and that deficits in anti-mycobacterial immunity will predict acquisition of Mtb infection. Using clinically-well characterized longitudinal cohorts of infants and children in Kenya, we will perform a comprehensive analysis of the phenotype, function, epigenome and transcriptome of innate immune responses in HEU, HIV-infected, and HIV-unexposed uninfected infants. We will then determine the capacity of ART to restore innate and adaptive anti-mycobacterial immune responses in HIV-infected children and identify immune correlates that predict acquisition of Mtb infection. These studies will provide unprecedented insights into mechanisms of HIV-associated modulation of immunity to Mtb in infants and children and will inform novel TB preventive interventions in these at-risk populations.

项目概要/摘要每年有超过 100 万儿童结核病 (TB) 新病例和 239,000 例与结核病相关的死亡。尽管有证据表明儿童接触艾滋病毒与感染艾滋病毒的风险显着增加有关结核分枝杆菌 (Mtb) 和结核病的发展，很少有研究探讨其机制儿童中与艾滋病毒相关的结核病易感性暴露于艾滋病毒的未感染儿童 (HEU) 在子宫内暴露于结核病。母亲艾滋病毒和抗逆转录病毒治疗（ART），这些暴露可能会影响随后的免疫对结核分枝杆菌的反应在艾滋病毒和结核病高发地区，新生儿通常会接种卡介苗。在生命的最初几天内，这可以为幼儿提供一定程度的预防严重结核病的保护。奇怪的是，卡介苗疫苗也被认为可以带来非特异性的有益效果，包括此外，接种卡介苗可降低新生儿和婴儿死亡率。对分枝杆菌和异源病原体的免疫反应，这种现象被称为“经过训练的先天免疫细胞（包括单核细胞和 NK 细胞）的表观遗传重编程就是其中之一。已确定的机制有助于卡介苗诱导的免疫力的提高。和婴儿 HIV 感染对 BCG 疫苗接种婴儿中受训练的 Mtb 免疫力的影响尚未被研究我们的研究将描述对分枝杆菌、辅助因子的先天性和适应性免疫反应的特征。例如可能影响免疫反应的 ART，以及这些免疫反应对我们将检验以下假设：(1) 母亲艾滋病毒暴露和婴儿。 HIV 感染通过先天免疫的表观遗传重编程抑制对 Mtb 训练有素的免疫力的诱导 (2) ART 增强先天性和适应性抗分枝杆菌免疫 HIV 感染儿童的反应以及抗分枝杆菌免疫力的缺陷将预测获得使用肯尼亚婴儿和儿童的临床特征良好的纵向队列，我们将对先天免疫的表型、功能、表观基因组和转录组进行全面分析然后，我们将确定 HEU、HIV 感染者和未接触 HIV 的未感染婴儿的反应能力。 ART 可恢复 HIV 感染儿童的先天性和适应性抗分枝杆菌免疫反应并确定这些研究将提供前所未有的见解，以预测 Mtb 感染的免疫相关性。研究婴儿和儿童中与 HIV 相关的 Mtb 免疫调节机制，并将为新的研究提供信息对这些高危人群进行结核病预防干预。